Profil
David S.
Ege currently works at ADC Therapeutics SA, as Chief Technical Officer from 2024.
Dr. Ege also formerly worked at Merck & Co., Inc., as Executive Director-Vaccines & Biologics from 2015 to 2019, Penn Biotech Group Healthcare Consulting, as President, and Seres Therapeutics, Inc., as Chief Technology Officer & Executive VP from 2020 to 2024.
Dr. Ege received his doctorate degree from the University of Pennsylvania and undergraduate degree from Princeton University.
Aktive Positionen von David Ege
| Unternehmen | Position | Beginn |
|---|---|---|
| ADC THERAPEUTICS SA | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2024 |
Ehemalige bekannte Positionen von David Ege
| Unternehmen | Position | Ende |
|---|---|---|
| SERES THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.10.2024 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01.06.2019 |
Penn Biotech Group Healthcare Consulting
Penn Biotech Group Healthcare Consulting Miscellaneous Commercial ServicesCommercial Services Operates as a student organization which provides project services on health and biotechnology sector | Präsident | - |
Ausbildung von David Ege
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADC Therapeutics SA
ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Seres Therapeutics, Inc.
Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Penn Biotech Group Healthcare Consulting
Penn Biotech Group Healthcare Consulting Miscellaneous Commercial ServicesCommercial Services Operates as a student organization which provides project services on health and biotechnology sector | Commercial Services |
















